Traditional medicine practices among community members with chronic kidney disease in northern Tanzania: an ethnomedical survey

Abstract

BackgroundIn sub-Saharan Africa, chronic kidney disease (CKD) is being recognized as a non-communicable disease (NCD) with high morbidity and mortality. In countries like Tanzania, people access many sources, including traditional medicines, to meet their healthcare needs for NCDs, but little is known about traditional medicine practices among people with CKD. Therefore, we sought to characterize these practices among community members with CKD in northern Tanzania.MethodsBetween December 2013 and June 2014, we administered a previously-developed survey to a random sample of adult community-members from the Kilimanjaro Region; the survey was designed to measure traditional medicine practices such as types, frequencies, reasons, and modes. Participants were also tested for CKD, diabetes, hypertension, and HIV as part of the CKD-AFRiKA study. To identify traditional medicines used in the local treatment of kidney disease, we reviewed the qualitative sessions which had previously been conducted with key informants.ResultsWe enrolled 481 adults of whom 57 (11.9 %) had CKD. The prevalence of traditional medicine use among adults with CKD was 70.3 % (95 % CI 50.0–84.9 %), and among those at risk for CKD (n = 147; 30.6 %), it was 49.0 % (95 % CI 33.1–65.0 %). Among adults with CKD, the prevalence of concurrent use of traditional medicine and biomedicine was 33.2 % (11.4–65.6 %). Symptomatic ailments (66.7 %; 95 % CI 17.3–54.3), malaria/febrile illnesses (64.0 %; 95 % CI 44.1–79.9), and chronic diseases (49.6 %; 95 % CI 28.6–70.6) were the most prevalent uses for traditional medicines. We identified five plant–based traditional medicines used for the treatment of kidney disease: Aloe vera, Commifora africana, Cymbopogon citrullus, Persea americana, and Zanthoxylum chalybeum.ConclusionsThe prevalence of traditional medicine use is high among adults with and at risk for CKD in northern Tanzania where they use them for a variety of conditions including other NCDs. Additionally, many of these same people access biomedicine and traditional medicines concurrently. The traditional medicines used for the local treatment of kidney disease have a variety of activities, and people with CKD may be particularly vulnerable to adverse effects. Recognizing these traditional medicine practices will be important in shaping CKD treatment programs and public health policies aimed at addressing CKD.Electronic supplementary materialThe online version of this article (doi:10.1186/s12882-015-0161-y) contains supplementary material, which is available to authorized users.

Prevalence and Risk Factors for Chronic Kidney Disease in Family Relatives of a Cameroonian Population of Hemodialysis Patients: A CrossSectional Study

“…1,2 The prevalence rate in the current study (15.85%) was analogous to prevalence rates varying between 14.6% and 15.8% observed in Asia. 20,21 This finding showed that relatives of CKD patients are at increased risk of CKD possibly because of a genetic link or environmental exposure.…”

“…12 Although reports on the prevalence and risk factors for CKD in family relatives of affected patients exist elsewhere, [13][14][15][16] such invaluable data is scarce in SSA where other potential contributing factors like chronic infections (e.g., HIV/AIDS, 17 hepatitis B and C infections 18 ) and herbal remedies abuse are very frequent and likely to aggravate the burden of CKD. [19][20][21]…”

Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action

“…17 Another peculiarity of CKD in LMICs includes the widespread use of herbal medications that cause chronic interstitial nephritis. 18 Also, the high prevalence of fake and counterfeit medicines (as much as 10%-60%) in LMICs 19,20 may be a significant cause of CKD though not well quantified. The relatively high incidence of hematologic disorders like sickle cell anaemia 21,22 and the sickle cell trait 23,24 and other hemoglobinopathies 24 in West African communities may also contribute to the higher CKD prevalence and increased variability regarding CKD in LMICs.…”

The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study

“…Individuals living in sub-Saharan Africa may have a heightened CKD risk similar to African Americans due to shared genetic susceptibility, such as that arising from apolipoprotein L1 (APOL1) gene risk variants and sickle cell trait [4][5][6][7]. CKD risk may be further exacerbated by HIV infection and its treatment [8], the rising prevalence of hypertension [9], and diabetes [10], as well as the use of potentially nephrotoxic traditional herbal medicines [11][12][13]. In sub-Saharan Africa, life-saving renal replacement therapy (dialysis or kidney transplantation) is not readily available, and consequently, those who progress to end-stage renal disease (ESRD) die prematurely.…”